Skip to main content
TipRanks
Go Ultimate75% OFF

Arcadia Biosciences (17D) Q1 2025 Earnings Report

0 Followers

DE:17D Q1 2025 EPS Results

Actual EPS
EUR 1.73
Consensus EPS
-EUR 0.89
Beat/Miss
Beat by +EUR 2.62
One Year Ago EPS
-EUR 1.62

DE:17D Q1 2025 Revenue Results

Actual Revenue
EUR 1.09M
Expected Revenue
EUR 1.18M
Beat/Miss
Missed by -EUR 90.95K
YoY Revenue Growth
-4.38%

Earnings Announcement Details

Quarter
Q1 2025
Date
05/08/2025
Time
Before Open
Conference Call
Thursday, May 8, 2025
DE:17D Upcoming Earnings

Arcadia Biosciences's next earnings date is estimated for April 1, 2027, based on past reporting schedules.

Q1 2025 Earnings Call Audio

DE:17D Q1 2025 Earnings Call
0:00 / 0:00

Q1 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2025 Earnings Call Summary

Q1 2025
Earnings Call Date:May 08, 2025|% Change Since:0.00%|
Earnings Call Sentiment|Positive

The earnings call reflected a strong start to 2025, with significant revenue growth in the Zola brand and effective cost control measures. However, challenges such as a decline in gross margin and an increase in inventory and cash consumption were noted. The pending business combination with Roosevelt Resources is a positive development, enhancing future prospects.

Company Guidance

During the Arcadia Biosciences, Inc. first-quarter 2025 conference call, significant growth and strategic shifts were highlighted. The company reported a remarkable 90% year-over-year increase in revenue for its Zola coconut water, primarily due to a 70% rise in new distribution channels. Operating expenses saw a 16% reduction, despite incurring nearly half a million dollars in transaction-related fees. The gross margin stood at 43%, maintaining a trend of exceeding 30% for nine consecutive quarters. Arcadia continued to monetize its intellectual property, securing $750,000 in cash for certain soy patents, which allowed for the elimination of a $1,000,000 contingent liability. The pending business combination with Roosevelt Resources is progressing, aiming for completion by late summer, with a fixed equity share ratio of 90-10 between Roosevelt Partners and Arcadia stockholders. The call also mentioned a strong pipeline and new product innovations expected to further boost Zola's market presence. Overall, the company is focused on streamlining operations and enhancing financial performance in 2025.

  • Zola Revenue GrowthZola coconut water revenue grew 90% year-over-year, driven by a 70% increase in new distribution gains.
  • Strong Pipeline and Distribution ExpansionZola is in discussions with new customers and distributors, representing more than 50% of its current customer base, and has already won new customer accounts in Q2.
  • Cost Control and Operating Expense ReductionOperating expenses were reduced by 16% year-over-year, inclusive of transaction-related fees.
  • Monetization of Intellectual PropertyArcadia entered an agreement with BioSeries, resulting in $750,000 in cash and the elimination of a $1,000,000 contingent liability from the balance sheet.
  • Pending Business CombinationThe business combination with Roosevelt Resources is on track to be completed by the end of the summer, providing Arcadia stockholders with a greater level of ownership certainty post-transaction.

DE:17D Earnings History

DE:17D earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 01, 20272026 (Q4)―--1.92――
Nov 12, 20262026 (Q3)―0.26-0.77134.20% (+1.04)
Aug 13, 20262026 (Q2)―-1.90-2.9735.89% (+1.06)
May 14, 20262026 (Q1)―-1.921.73-211.05% (-3.65)
Mar 26, 20262025 (Q4)-0.60-0.88-2.7167.45% (+1.83)
Nov 07, 20252025 (Q3)-0.49-0.77-1.0728.14% (+0.30)
Aug 14, 20252025 (Q2)-0.72-2.970.71-517.95% (-3.67)
May 08, 20252025 (Q1)-0.891.73-1.62206.74% (+3.35)
Mar 20, 20252024 (Q4)-0.81-2.71-1.91-41.90% (-0.80)
Nov 12, 20242024 (Q3)-0.74-1.07-1.7237.57% (+0.65)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed